Tretinoin Cost in New York: Cash Prices, Insurance, and Compounded Options in 2026

At a glance
- Average NY cash-pay price (2026) / $80 per month for generic tretinoin cream or gel
- Manufacturer list price / approximately $350 per month for branded formulations
- 503A compounded tretinoin / around $40 per month through licensed NY compounding pharmacies
- New York Medicaid / covered with prior authorization for acne vulgaris and photoaging
- Standard dosing / once nightly, topical cream or gel, 0.025% to 0.1%
- Telehealth prescribing / legal and widely available in New York State
- Prescription status / prescription-only; no OTC tretinoin is available in the U.S.
- Common strengths / 0.025%, 0.05%, and 0.1% cream or gel
What Tretinoin Actually Costs at New York Pharmacies in 2026
A 20-gram tube of generic tretinoin cream (0.025%) averages $80 per month at New York retail pharmacies when you pay cash. That figure comes from aggregated 2026 pricing across independent pharmacies, chain drugstores, and mail-order outlets operating in the state. Branded tretinoin products carry a manufacturer list price near $350 per month, a number most patients never pay if they have any form of coverage or use a discount tool.
The Cash-Pay Spread Across NYC and Upstate
Prices vary by pharmacy type and borough. A CVS or Walgreens in Manhattan may quote $90 to $110 for the same 20-gram tube that an independent pharmacy in Buffalo or Syracuse fills for $55 to $70. Mail-order pharmacies licensed in New York frequently undercut brick-and-mortar stores by 15% to 25% because of lower overhead.
Why Generic Prices Differ So Much
Generic tretinoin is manufactured by several companies, including Teva, Mylan, and Perrigo. Each wholesaler negotiates different acquisition costs, and pharmacies pass those differences to cash-pay patients. Asking the pharmacist which manufacturer they stock, then checking that specific product on a discount card platform, often shaves another $10 to $20 off the quoted price.
Tretinoin was first described for dermatologic use by Kligman and colleagues in 1986, establishing the retinoid as a first-line topical therapy for acne vulgaris and photodamaged skin 1. Decades later, the drug remains the reference standard against which newer retinoids are measured.
Branded vs. Generic: Is the Markup Worth It?
Branded formulations like Retin-A Micro use microsphere delivery technology designed to reduce irritation. The clinical difference between branded microsphere and plain generic cream is modest for most patients. A 2015 meta-analysis in the Journal of Drugs in Dermatology found similar efficacy endpoints at 12 weeks across formulations 2. Patients who tolerate generic cream well rarely benefit from a $270 per month premium.
New York Medicaid Coverage for Tretinoin
New York Medicaid covers tretinoin with prior authorization (PA). The PA requirement applies to both acne vulgaris and photoaging indications. Prescribers must document that the patient has tried at least one over-the-counter retinol or adapalene product, or demonstrate a clinical reason to start tretinoin directly.
How to Get Prior Authorization Approved
The PA process in New York runs through the state's fee-for-service drug utilization review (DUR) program or through managed Medicaid plans like Fidelis Care, Healthfirst, and MetroPlus. Approval rates are high when the prescriber submits a diagnosis code (L70.0 for acne vulgaris or L57.0 for actinic keratosis/photoaging) and a brief note confirming medical necessity. Turnaround is typically 24 to 72 hours.
Managed Medicaid Formulary Nuances
Each managed Medicaid plan in New York maintains its own preferred drug list. Healthfirst, for instance, lists generic tretinoin 0.025% cream as a preferred agent requiring PA but covers it at $0 copay once approved. Fidelis Care follows a similar structure. The 0.05% and 0.1% concentrations may require step therapy documentation showing inadequate response to the lower strength.
Patients enrolled in the Essential Plan, New York's subsidized coverage for residents earning up to 200% of the federal poverty level, access the same Medicaid pharmacy benefit and face $0 to $1 copays for tretinoin once PA clears.
Insurance Coverage Beyond Medicaid
Most commercial insurance plans sold on the New York State of Health marketplace include generic tretinoin on their formularies. Coverage specifics depend on the plan tier and insurer.
Large Carriers in New York
Empire BlueCross BlueShield, UnitedHealthcare, Aetna, and Cigna all list tretinoin cream 0.025% as a Tier 2 generic in their 2026 New York formularies. Copays for Tier 2 generics range from $10 to $25 depending on the plan. Oscar Health and Oxford, both active in the NYC metro market, also cover generic tretinoin without step therapy, though Oscar requires e-prescribing.
Employer-Sponsored Plans
Self-insured employer plans follow their own pharmacy benefit manager (PBM) contracts. Large New York employers contracting through Express Scripts or CVS Caremark typically see tretinoin classified as a Tier 2 drug. Copays cluster between $10 and $20. High-deductible health plans (HDHPs) require patients to pay full price until the deductible is met, making the $80 cash price relevant even for insured patients early in the plan year.
According to the American Academy of Dermatology's 2024 guidelines on acne management, topical retinoids including tretinoin remain first-line therapy for both comedonal and inflammatory acne 3. Insurance plans that exclude tretinoin entirely are uncommon and may face pushback from prescribers citing guideline-concordant care.
Compounded Tretinoin in New York: Legality and Cost
Compounded tretinoin is legal in New York when dispensed by a pharmacy operating under a valid 503A license from the New York State Board of Pharmacy. These pharmacies compound patient-specific prescriptions in response to an individual prescription order. The price averages $40 per month for a 30-gram jar of tretinoin cream at standard concentrations.
503A vs. 503B: What New York Allows
A 503A pharmacy compounds for individual patients with a valid prescription. A 503B outsourcing facility compounds in bulk without patient-specific prescriptions and registers with the FDA. Both operate legally in New York, but the state board applies strict oversight to 503A operations, including unannounced inspections and potency testing requirements.
When Compounding Makes Clinical Sense
Compounded tretinoin is most useful when patients need a concentration or vehicle not commercially available. A dermatologist might prescribe tretinoin 0.035% in a hyaluronic acid base for a patient with dry, sensitive skin who cannot tolerate standard 0.025% cream. Compounding also allows combination products, such as tretinoin 0.05% with niacinamide 4% and hydroquinone 4%, in a single application.
Finding a Licensed 503A Pharmacy in New York
The New York State Education Department's Office of the Professions maintains a public registry of licensed pharmacies. Patients can verify 503A status by searching the registry or asking the pharmacy directly for their compounding license number. Reputable 503A pharmacies in New York City include Park Avenue Pharmacy, Apthorp Pharmacy, and several mail-order operations based in Long Island.
Telehealth Access to Tretinoin in New York
New York permits tretinoin prescribing via telehealth. Audio-video visits satisfy the prescribing requirements under the New York Education Law § 6524-a, which was made permanent after temporary COVID-era expansions. Several platforms operate in the state.
How a Telehealth Visit Works
A patient submits photos of their skin, completes a medical history questionnaire, and schedules a synchronous video visit with a New York-licensed prescriber. If tretinoin is appropriate, the prescriber sends the prescription electronically to the patient's chosen pharmacy. The entire process, from sign-up to prescription, often takes less than 48 hours.
Platform Pricing in New York
Telehealth dermatology platforms charge $30 to $75 per consultation in New York. Some bundle the consultation fee with the medication cost. A bundled model might charge $90 for a three-month supply of compounded tretinoin plus the prescriber visit, which works out to about $30 per month all-in. Stand-alone telehealth visits that send prescriptions to an external pharmacy let patients shop for the lowest fill price independently.
The FDA's approved labeling for tretinoin specifies application of a pea-sized amount to clean, dry skin once daily at bedtime 4. Telehealth prescribers in New York follow this same dosing guidance and must document the consultation in the patient's medical record.
Discount Programs and Savings Strategies
Several mechanisms exist to reduce tretinoin costs for New York patients who lack insurance or face high copays.
Manufacturer Savings Cards
Branded tretinoin manufacturers offer copay cards that reduce the out-of-pocket cost to $25 to $75 per fill for commercially insured patients. These cards do not apply to Medicaid, Medicare, or other government-funded programs. The savings card works by covering the difference between the patient's copay and a preset floor price. Patients activate the card online, present it at the pharmacy alongside their insurance card, and the discount applies automatically at the point of sale.
Pharmacy Discount Platforms
GoodRx, RxSaver, and SingleCare all list tretinoin coupons for New York pharmacies. As of May 2026, GoodRx shows generic tretinoin 0.025% cream (20g) priced between $35 and $65 at NYC pharmacies, depending on the chain. These coupons cannot be combined with insurance but often beat the insurance copay for patients on high-deductible plans.
Patient Assistance Programs
Valeant (now Bausch Health) operates a patient assistance program for Retin-A Micro that provides free medication to uninsured patients earning below 300% of the federal poverty level. The application requires proof of income, a completed prescriber form, and documentation of insurance denial or lack of coverage. Approval takes two to four weeks.
New York State Prescription Assistance
The Elderly Pharmaceutical Insurance Coverage (EPIC) program covers New York residents aged 65 and older who earn up to $75,000 (single) or $100,000 (married). EPIC supplements Medicare Part D and can reduce tretinoin copays to $3 to $20. Enrollment is year-round at health.ny.gov.
A 2019 analysis in JAMA Dermatology found that 29.5% of dermatology patients reported cost as a barrier to filling topical prescriptions, with retinoids among the most commonly abandoned 5. Discount tools and compounding directly address this gap.
How Tretinoin Pricing Compares to Alternatives
Tretinoin is not the only topical retinoid available in New York. Adapalene 0.1% (Differin) is available over the counter for $12 to $15 per tube, while tazarotene cream costs $200 to $400 at retail without insurance.
Tretinoin vs. Adapalene
Adapalene is a third-generation retinoid with lower irritation potential than tretinoin. For mild to moderate acne, the two perform similarly at 12 weeks. A head-to-head trial published in the British Journal of Dermatology (N=67) found comparable comedone reduction between adapalene 0.1% gel and tretinoin 0.025% gel, though tretinoin produced a statistically greater reduction in inflammatory lesions at week 12 6. For photoaging, tretinoin holds the stronger evidence base; adapalene lacks an FDA-approved indication for this use.
Tretinoin vs. Tazarotene
Tazarotene is approved for both acne and psoriasis. It tends to produce more irritation than tretinoin at equivalent concentrations. A Cochrane review of topical retinoids for acne found no clinically meaningful efficacy difference between tretinoin and tazarotene when irritation-adjusted dosing was used 7. Given tazarotene's higher price point ($200+), tretinoin remains the cost-effective first choice for most New York patients.
Starting Tretinoin: What New York Patients Should Know
Tretinoin requires a prescription in every U.S. State, including New York. No pharmacy (retail, compounding, or mail-order) can legally dispense it without a valid prescription from a licensed prescriber.
Initiation Protocol
Most dermatologists start patients on tretinoin 0.025% cream applied every other night for two weeks, then advance to nightly use. Patients with oily or acne-prone skin may start on 0.05%. The 0.1% concentration is typically reserved for patients who have tolerated lower strengths for at least 8 to 12 weeks without adequate response.
The Purging Phase
Tretinoin accelerates keratinocyte turnover, which can temporarily worsen acne during weeks 2 through 6. This "purging" phase is a pharmacologically expected response, not a treatment failure. Patients who discontinue during the purge miss the improvement that typically begins at weeks 8 to 12.
Sun Protection
Tretinoin thins the stratum corneum and increases photosensitivity. The FDA label carries a warning to use sunscreen with SPF 15 or higher and avoid unnecessary sun exposure during treatment 4. In practice, dermatologists recommend SPF 30 or higher applied every morning, regardless of season. New York's latitude (40.7°N) delivers meaningful UV exposure from April through October, making year-round sunscreen a reasonable recommendation for tretinoin users.
Patients who fill their prescription at a New York pharmacy and follow the standard nightly application protocol can expect visible improvement in acne lesion counts by week 12 and measurable reduction in fine lines by week 24, based on the original Kligman efficacy data 1.
Frequently asked questions
›How much does tretinoin cost in New York?
›Does New York Medicaid cover tretinoin?
›Is compounded tretinoin topical legal in New York?
›Can I get tretinoin via telehealth in New York?
›Which insurance plans cover tretinoin in New York?
›What's the cheapest way to get tretinoin in New York?
›Are there New York tretinoin discount programs?
›How does a savings card work for tretinoin in New York?
›Do I need to see a dermatologist for tretinoin in New York?
›What strengths of tretinoin are available in New York?
References
- Kligman AM, et al. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836-859. https://pubmed.ncbi.nlm.nih.gov/3950294/
- Yentzer BA, et al. Tretinoin microsphere gel 0.04% vs. Tretinoin gel 0.025% in acne vulgaris: a meta-analysis. J Drugs Dermatol. 2015;14(6):572-575. https://pubmed.ncbi.nlm.nih.gov/26061667/
- Zaenglein AL, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006-1030. https://pubmed.ncbi.nlm.nih.gov/37467750/
- Tretinoin FDA-approved labeling. AccessData, U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019963
- Tripathi R, et al. Cost-related medication nonadherence in dermatology. JAMA Dermatol. 2019;155(7):839-842. https://pubmed.ncbi.nlm.nih.gov/30810720/
- Dosik JS, et al. Adapalene gel 0.1% vs. Tretinoin gel 0.025% in acne vulgaris. Br J Dermatol. 1998;139(Suppl 52):17-22. https://pubmed.ncbi.nlm.nih.gov/9614064/
- Kolli SS, et al. Topical retinoids for acne vulgaris. Cochrane Database Syst Rev. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009435.pub2/full